Small molecule shows promise as anti-cancer therapy
Johns Hopkins scientists say a previously known but little studied chemical compound targets and shuts down a common cancer process. In studies of laboratory-grown human tumor cell lines, the drug disrupted tumor cell division ...
Jan 13, 2014
0
0